Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

Breast cancer; Prone or not Prone??

ESRA ARSLAN, Tamer AKSOY, Tevfik Cermik and Fadime Can Trabulus
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1239;
ESRA ARSLAN
2Istanbul Research and Education Hospital Clinic of Nuclear Medicine University of Health Sciences Istanbul Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamer AKSOY
2Istanbul Research and Education Hospital Clinic of Nuclear Medicine University of Health Sciences Istanbul Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tevfik Cermik
2Istanbul Research and Education Hospital Clinic of Nuclear Medicine University of Health Sciences Istanbul Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fadime Can Trabulus
1Istanbul Research and Education Hospital Clinic of General Surgery University of Health Sciences Istanbul Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1239

Objectives: Prone position 18F fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) may improve the localization of the tumor, delineate the exact distance from areola which is utmost important for the surgical planning and separation of deep anatomic parts especially axillary lymph nodes. The aim of this study was to compare the PET CT metabolic and anatomic parameters by prone versus supine 18 FDG-PET in newly diagnosed breast cancer. MATERIALS AND METHODS: Locally Institutional Review Board approved this prospective study. Total of 39 breast cancer patients whom newly diagnosed underwent both prone and supine FDG-PET/CT at the same scanning day. Two readers performed an independent review of all scans. Differences between the observers were resolved at a consensus reading session. Primary tumor SUVmax, SUV peak, SUVmean40%, MTV40%, TLG40, Thresh40, SUVmean70%, MTV70%, TLG70, and Thresh 70 values were calculated for both supine and prone positions. Also, differences between distance of primary tumor from the areola and pectoral muscle involvements and axillary lymph node status were evaluated by two interpreters.

Results: Prone position mean primary tumor SUVmax was 12,78±8,91, supine position mean primary tumor SUVmax was 13,26±9,73. Categorization of anatomic disease distribution has concordant between prone and supine scanning in 35 patients. Prone position; mean 40% MTV±STD:13±25 and mean 70%MTV±STD:1,98±2,53. Supine position mean40% MTV was 13,87±25,54 and mean70%MTV was 2,26±2,85. By far away prone position gives better anatomical location, exact distance from the areola and gives better visual assessment ability of pectoral muscle; as expected. In the 27 patients with breast and axillary disease, equal numbers of metastatic lymph nodes were identified on prone and supine scanning in 15 patients, whereas in the remaining 12 patients, prone scanning diagnosed in a higher number of visualized lymph nodes.

Conclusions: Both prone and supine position FDG-PET/CT scanning gives identical information on locoregional disease distribution in Locally Advanced Breast Cancer. But prone position scanning may perform better than supine for assessing the number of metastatic lymph nodes, distance from the areola and delineation of pectoral muscle involvement. Prone position FDG-PET/CT may be useful for surgical planning in future clinical and research studies, including PET and magnetic resonance imaging (MRI) fusion applications.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Breast cancer; Prone or not Prone??
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Breast cancer; Prone or not Prone??
ESRA ARSLAN, Tamer AKSOY, Tevfik Cermik, Fadime Can Trabulus
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1239;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Breast cancer; Prone or not Prone??
ESRA ARSLAN, Tamer AKSOY, Tevfik Cermik, Fadime Can Trabulus
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1239;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Assessment of incidental pituitary uptake on FDG PET/CT scan: Digital vs. conventional PET/CT
  • Zero TE-based PET/MR attenuation correction in patients with oral cavity cancer
Show more Oncology: Clinical Therapy and Diagnosis

Breast Cancer Posters

  • The importance of 18F-FDG PET/CT in staging male breast carcinoma
  • Correlation between 18F-FDG PET/CT standardized uptake value with prognostic factors and gene expression profiles in breast cancer: Single center study from Azerbaijan
  • Relationship between tumor markers, Ca 15-3 and Ca 125, levels and Sodium-18 Fluoride Positron Emission Tomography Scan in breast cancer bone metastasis
Show more Breast Cancer Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire